|
Trending:
4P
0
Almost half of diabetics are cutting back on treatment because of costs, according to a new survey that comes as the skyrocketing price of insulin is prompting lawmakers and physicians to call for more oversight.
U.S. regulators on Tuesday approved a new diabetes drug that reduces blood sugar levels and also helps people lose significant weight.
More than 29 million Americans live with diabetes, and for some six million of them, insulin is a life or death medication.